What’s the secret to aging well? University of Minnesota Medical School researchers have answered it- on a cellular level.
Aging starts in our cells, and those aging cells can hasten cellular senescence, leading to tissue dysfunction and related health impacts.
New research involving University of Minnesota Medical School faculty Paul D. Robbins and Laura J. Niedernhofer, recently published in Nature Medicine, shows there are types of small molecules called senolytics that can reverse the impact of aged, senescent cells.
“We’ve always thought of aging as a process, not a disease,” said Dr. Robbins, Associate Director of the newly founded Institute on the Biology of Aging and Metabolism (iBAM). “But what if we can influence the impacts of aging at a cellular level to promote healthy aging? That’s what senolytics seeks to achieve.”
The research determined whether introducing senescent cells to human and animal tissue would impact the cellular health of surrounding cells. Surprisingly, the transplant of a relatively small number of senescent cells caused persistent physical dysfunction as well as the spread of cellular senescence in previously healthy cells.
In addition, researchers found that a high fat diet, which causes a type of metabolic stress, or simply being old, enhances the physical dysfunction that comes from senescent cells.
“Previous research has shown that our immune system’s ability to eliminate or deal with senescent cells is based 30 percent on genetics and 70 percent on environment,” said Dr. Robbins, noting that what we eat and how often we exercise can affect senescence or aging of cells.
Conversely, the researchers determined that treatment with senolytic drugs, able to eliminate senescent cells, can reverse physical dysfunction and actually extend lifespan even when used in aged animal models.
“We saw greater activity, more endurance, and greater strength following use of senolytics,” said Dr. Robbins.
The paper notes that the results provide proof-of-concept evidence that improved health and lifespan in animals is possible by targeting senescent cells. The hope is that senolytics will prove effective in alleviating physical dysfunction and resulting loss of independence in older adult humans as well.
“This area of research is promising, not just to address the physical decline that comes with aging, but also to enhance the health of cancer survivors treated with radiation or chemotherapy – two treatments that can induce cell senescence,” said Laura Niedernhofer, Director of iBAM.
The Latest on: Senolytic drugs
[google_news title=”” keyword=”senolytic drugs” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Senolytic drugs
- Enhanced Potential of Myricx’s NMT Inhibitor Payloads with Dual Senolytic and Cytotoxic Modes of Action as ADC Cancer Therapieson November 27, 2023 at 8:40 am
Data published today in Nature Cell Biology by Myricx collaborators at the MRC-LMS (Laboratory of Medical Sciences) led by Prof. Jesús Gil have ...
- Cellular Aging and Age-Related Illnesson November 23, 2023 at 9:29 pm
Dasatinib, Quercetin, Fisetin, and Navitoclax are drugs that specifically kill senescent cells and are recognized as senolytic drugs. On the other hand, senomorphic drugs inhibit the production of ...
- Drugs identified that may reverse brain fog caused by COVID-19on November 22, 2023 at 6:18 pm
Experimenting on lab-grown mini-brains and mice, researchers have found that SARS-CoV-19 infection can cause ‘zombie’ cells to accumulate, contributing to the brain fog associated with long COVID, and ...
- University of Queensland trial on mice, tissue cells, a potential first step in treating COVID-19 brain fogon November 21, 2023 at 12:00 pm
The scientists found that four pre-existing drugs successfully eliminated cells that were found to speed up the effects of ageing on the brain, so-called "zombie" cells that grew faster in a COVID-19 ...
- Senolytics show promise in combating brain aging and COVID-19 neuropathologyon November 14, 2023 at 4:00 pm
Senolytics are a class of drugs that selectively target and eliminate senescent ... aging and COVID-19 pathology in the central nervous system remains unknown. Study: Senolytic therapy alleviates ...
- Senescence of endplate osteoclasts induces sensory innervation and spinal painon November 13, 2023 at 4:00 pm
We show that deletion of senescent cells by administration of the senolytic drug Navitoclax (ABT263) results in significantly less spinal hypersensitivity, spinal degeneration, porosity of the ...
- Groundbreaking new drug could extend human life by 30%on November 9, 2023 at 4:01 pm
In the future, protecting our cells from aging could be as easy as taking a pill. Mayo Clinic researchers have found that senolytic drugs can increase the production of a crucial protein, potentially ...
via Bing News